Phospholipases A2 < Phospholipid < Phospholipid abnormalities

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f KwdFr.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references indexed by Phospholipid

Number of relevant bibliographic references: 87.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
001200 (2013)	Hong Boe Tjiong ; Jochen Lepthin ; Hildegard Debuch	Lysosomal Phospholipids from Rat Liver after Treatment with Different Drugs
001394 (2012)	David Keeling [Royaume-Uni] ; Ian Mackie [Royaume-Uni] ; Gary W. Moore [Royaume-Uni] ; Ian A. Greer [Royaume-Uni] ; Michael Greaves [Royaume-Uni]	Guidelines on the investigation and management of antiphospholipid syndrome
001552 (2011)	Katarzyna R. Przybylak [Royaume-Uni] ; Mark T. D. Cronin [Royaume-Uni]	In Silico Studies of the Relationship Between Chemical Structure and Drug Induced Phospholipidosis
001819 (2009)	Juha-Matti Alakoskela [Finlande] ; Pavol Vitovi [Finlande] ; Paavo Kinnunen [Finlande, Danemark]	Screening for the Drug–Phospholipid Interaction: Correlation to Phospholipidosis
001866 (2009)		Herbsttagung der Gesellschaft für Biologische Chemie
001875 (2009)	David Karabelnik ; Gerhard Zbinden	Drug-Induced Foam Cell Reactions in Rats, II. Chemical Analysis of Lipids Stored in Lungs and Foam Cells after Treatment with Chlorphentermine, 5-[p-(Fluoren-9-ylidenemethyl)phenyl]-2-piperidineethanol (RMI 10.393) and 1-Chloramitriptyline
001B09 (2007)	Suryanaryana Vangapandu [Inde, États-Unis] ; Meenakshi Jain [Inde] ; Kirandeep Kaur [Inde] ; Premanand Patil [Inde] ; Sanjay R. Patel [Inde] ; Rahul Jain [Inde]	Recent advances in antimalarial drug development
001F00 (2005)	Michael L. Cunningham ; Lois Lehman-Mckeeman	Applying Toxicogenomics in Mechanistic and Predictive Toxicology
002005 (2004)	M. Akif Öztürk ; Ibrahim C. Haznedaro Lu [Turquie] ; Mehmet Turgut [Turquie] ; Hakan Göker [Turquie]	Current Debates in Antiphospholipid Syndrome: The Acquired Antibody-Mediated Thrombophilia
002136 (2003)	Anand N. Malaviya [Inde]	Antiphospholipid (Hughes) syndrome: a review with update
002570 (2000)	Zara R. Brenner [États-Unis] ; Sheila A. Myer [États-Unis]	Antiphospholipid antibody syndrome: Implications for nursing practice
002595 (1999)	S. M Song [République populaire de Chine] ; S. M Lu [République populaire de Chine] ; Z. G Wang [République populaire de Chine] ; J. C Liu [République populaire de Chine] ; S. Q Guo [République populaire de Chine] ; Z. Li [République populaire de Chine]	Subcellular membrane impairment and application of phospholipase A2 inhibitors in endotoxic shock
002611 (1999)	Władysława A. Daniel [Pologne] ; Jacek W Jcikowski [Pologne]	Lysosomal trapping as an important mechanism involved in the cellular distribution of perazine and in pharmacokinetic interaction with antidepressants
002634 (1999)	W. A. Daniel [Pologne] ; J. W Jcikowski [Pologne]	The Role of Lysosomes in the Cellular Distribution of Thioridazine and Potential Drug Interactions
002780 (1998)	Heribert Thaler	10 Fatty change
002857 (1997)	Jan Bondeson	The mechanisms of action of disease-modifying antirheumatic drugs: A review with emphasis on macrophage signal transduction and the induction of proinflammatory cytokines
002994 (1996)	Danièle Plein [Belgique] ; Guy Van Camp [Belgique] ; André Efira [Belgique] ; Alain Brunet [Belgique] ; Jean-Luc Vandenbossche [Belgique]	Intracardiac thrombi associated with antiphospholipid antibodies
002B30 (1995)	Ulrich E. Honegger [Suisse] ; Isabel Scuntaro [Suisse] ; Ulrich N. Wiesmann [Suisse]	Vitamin E reduces accumulation of amiodarone and desethylamiodarone and inhibits phospholipidosis in cultured human cells
002C08 (1994)	Jukka Mönkkönen [Finlande] ; Riitta Valjakka [Finlande] ; Maria Hakasalo [Finlande] ; Arto Urtti [Finlande]	The effects of liposome surface charge and size on the intracellular delivery of clodronate and gallium in vitro
002C17 (1994)	J. Zuidema [Pays-Bas] ; F. Kadir [Pays-Bas] ; H. A. C. Titulaer [Pays-Bas] ; C. Oussoren [Pays-Bas]	Release and absorption rates of intramuscularly and subcutaneously injected pharmaceuticals (II)
002C41 (1994)	Paulm. Rowe	Drug therapy for tropical disease

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Teeft.i -k "Phospholipid" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Teeft.i  \
                -Sk "Phospholipid" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Teeft.i
   |clé=    Phospholipid
}}

---

This area was generated with Dilib version V0.6.33. Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021